Back to search

Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia

Data up to Jan 2025

Published1995
Citations47
References33

Total Citations Per Year

Abstract

References (33)

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

1991 • 3,812 citations

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1990 • 865 citations

Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia

1993 • 850 citations

Increased plasma levels of interleukin-6 in sepsis [see comments]

1989 • 813 citations

Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways

1990 • 796 citations

Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever

1990 • 765 citations

Septic shock: pathogenesis

1991 • 743 citations

Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways

1990 • 611 citations

Toward an Epidemiology and Natural History of SIRS (Systemic Inflammatory Response Syndrome)

1992 • 479 citations

From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever

1990 • 405 citations

Anticytokine Strategies in the Treatment of the Systemic Inflammatory Response Syndrome

1993 • 397 citations

Septicemia and Shock Syndrome Due to Viridans Streptococci: A Case-Control Study of Predisposing Factors

1992 • 386 citations

Interleukin-10 production during septicaemia

1994 • 365 citations

Plasma Tumor Necrosis Factor in Patients with Septic Shock: Mortality Rate, Incidence of Adult Respiratory Distress Syndrome, and Effects of Methylprednisolone Administration

1990 • 335 citations

Plasma tumor necrosis factor and mortality in critically ill septic patients

1989 • 324 citations

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

1991 • 311 citations

Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.

1992 • 238 citations

Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease

1992 • 209 citations

Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.

1992 • 179 citations

Endogenous haemopoietic growth factors in neutropenia and infection

1994 • 178 citations

Release of tumor necrosis factor by human polymorphonuclear leukocytes

1990 • 144 citations

Efficacy of a Monoclonal Antibody Directed against Tumor Necrosis Factor in Protecting Neutropenic Rats from Lethal Infection with Pseudomonas aeruginosa

1990 • 123 citations

Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice

1992 • 110 citations

Interleukin-6 and Its Relationship to C-Reactive Protein and Fever in Children with Febrile Neutropenia

1992 • 99 citations

Role of Interferon- in Experimental Gram-Negative Sepsis

1992 • 90 citations

Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1β

1994 • 84 citations

Bioactive and Inactive Forms of Tumor Necrosis Factor- in Spinal Fluid from Patients with Meningitis

1991 • 64 citations

Cytokine and Acute-Phase Reactant Levels in Serum of Children with Cancer Admitted for Fever and Neutropenia

1992 • 61 citations

Cytokine mediators of septic infections in the normal and granulocytopenic host

1993 • 51 citations

Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy

1994 • 51 citations

Monitoring of endotoxin, interleukin‐6 and C‐reactive protein serum concentrations in neutropenic patients with fever

1995 • 51 citations

How gram-positive organisms cause sepsis

1993 • 42 citations

Trimethoprim-Sulfamethoxazole plus Amikacin as First-Line Therapy and Imipenem/Cilastatin as Second Empirical Therapy in Febrile Neutropenic Patients with Hematological Disorders

1992 • 20 citations

Cited By (0)

Loading...
Clinical significance of serum cytokine patterns during start of fever in patients with… (1995) – British Journal of Haematology | Metascience Observatory Explorer